Antimicrobial-induced hyponatremia: pathophysiological mechanisms, implicated agents, and clinical management strategies
European Journal of Clinical Pharmacology · 2026-07 · 82 (7)
DOI: 10.1007/s00228-026-04116-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 18.06.2026. Verfasst von Tianqi Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Beijing Hospital, National Center for Gerontology, National Clinical Research Center for Gerontology; The Key Laboratory of G…. Hauptthemen laut MEDLINE: Hyponatremia, Anti-Infective Agents. Die Arbeit nennt 98 Literaturangaben. Gefördert von: National High Level Hospital Clinical Research Fundin, Research project on high quality development of Hospital pharmacy, National Institute of Hospital Administration, NHC, China.
Abstract (Originalsprache)
Background
Hyponatremia is a prevalent and serious electrolyte disorder affecting approximately 20% of hospitalized patients, significantly increasing morbidity and mortality. While common causes are well-documented, antimicrobial-induced hyponatremia is frequently underrecognized due to confounding infection-related factors. This review aims to systematically delineate the implicated antimicrobial agents, their underlying pathophysiological mechanisms, and clinical management strategies.
Methods
A comprehensive literature search was conducted via PubMed for studies published between January 1, 2000, and August 22, 2025. Data were synthesized to categorize drugs based on risk levels, mechanisms of action, and clinical outcomes. Backward citation tracking was employed to identify additional pertinent cases and mechanistic studies.
Results
The primary pathophysiological drivers identified are the syndrome of inappropriate antidiuresis (SIAD) and direct renal tubular dysfunction. High-risk agents include linezolid, trimethoprim-sulfamethoxazole and voriconazole. Other implicated agents include fluoroquinolones, vidarabine, rifabutin, azithromycin, aminoglycosides, colistin, nitrofurantoin and β-lactam antibiotics. Onset typically occurs within 2 to 14 days of therapy initiation. Key risk factors identified include advanced age (≥ 65 years), renal impairment, supratherapeutic dosing, large-volume hypotonic diluents, and concomitant use of diuretics or SSRIs.
Conclusion
Antimicrobial-induced hyponatremia is an important clinical entity that necessitates a high index of suspicion, particularly in older adults and polymedicated patients. Management focuses on the prompt identification and withdrawal of the offending agent, followed by symptom-stratified sodium correction. This review provides a practical guide to mitigate risks. Future prospective studies are needed to elucidate the mechanisms and clinical characteristics of antimicrobial-induced hyponatremia. Clinical trial number Not applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Beijing Hospital, National Center for Gerontology, National Clinical Research Center for Gerontology; The Key Laboratory of Geriatrics of NHC; Institute of Geriatric Medicine, Chinese Academy of…
- Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical Sciences, Peking University, Beijing, 100191, P.R. China.
- Department of Pharmacy, Xizang Autonomous Region People's Hospital, Xizang, 850000, P.R. China.
ORCID-Profile: Pengfei Jin
Förderung
- National High Level Hospital Clinical Research Fundin
- Research project on high quality development of Hospital pharmacy, National Institute of Hospital Administration, NHC, China
Zitieren
APA
Liu, T., Li, R., Xu, W., Zhao, F., Huang, J., Liang, L., Zhu, Y., Zhao, Z., & Jin, P. (2026). Antimicrobial-induced hyponatremia: pathophysiological mechanisms, implicated agents, and clinical management strategies. European Journal of Clinical Pharmacology, 82(7). https://doi.org/10.1007/s00228-026-04116-5
Vancouver
Liu T, Li R, Xu W, Zhao F, Huang J, Liang L, et al. Antimicrobial-induced hyponatremia: pathophysiological mechanisms, implicated agents, and clinical management strategies. European Journal of Clinical Pharmacology. 2026;82(7). doi:10.1007/s00228-026-04116-5
BibTeX
@article{Liu2026,
author = {Liu, Tianqi and Li, Ruixue and Xu, Wenfeng and Zhao, Fei and Huang, Jing and Liang, Liang and Zhu, Yuanchao and Zhao, Zinan and Jin, Pengfei},
title = {Antimicrobial-induced hyponatremia: pathophysiological mechanisms, implicated agents, and clinical management strategies},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
volume = {82},
number = {7},
doi = {10.1007/s00228-026-04116-5}
}
EUVIMED